{"id":572855,"date":"2021-11-03T18:30:01","date_gmt":"2021-11-03T18:30:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=572855"},"modified":"2021-11-03T18:30:01","modified_gmt":"2021-11-03T18:30:01","slug":"parkinsons-disease-related-dementia-market-disease-risk-burden-unmet-needs-and-other-insights-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/parkinsons-disease-related-dementia-market-disease-risk-burden-unmet-needs-and-other-insights-by-delveinsight_572855.html","title":{"rendered":"Parkinson&#8217;s Disease Related Dementia Market: Disease Risk, Burden, Unmet Needs, and Other Insights by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1635930180.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Parkinson&#039;s Disease Related Dementia Market: Disease Risk, Burden, Unmet Needs, and Other Insights by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1635930180.jpeg\" alt=\"Parkinson&#039;s Disease Related Dementia Market: Disease Risk, Burden, Unmet Needs, and Other Insights by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Parkinson&#8217;s Disease Related Dementia Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s <strong>&#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/parkinsons-disease-related-dementia-market?utm_source=Sheeran&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Parkinson&#8217;s Disease Related Dementia Market<\/a> Insights, Epidemiology, and Market Forecast-2030&#8243;<\/strong>&nbsp;report delivers an in-depth understanding of the Parkinson&#8217;s Disease Related Dementia , historical and forecasted epidemiology as well as the Parkinson&#8217;s Disease Related Dementia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">Parkinson&#8217;s Disease Related Dementia is a condition that develops from Parkinson&rsquo;s Disease &#8211; a progressive neurological disorder causing damage to the central nervous system. A decline in reasoning, thinking, and problem-solving, are the primary markers of Parkinson&rsquo;s Disease Related Dementia. Around 50 to 80 percent of people with Parkinson&rsquo;s disease eventually experience Parkinson&rsquo;s Disease Related Dementia.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some facts of <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/parkinsons-disease-related-dementia-market?utm_source=Sheeran&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Parkinson&#8217;s Disease Related Dementia Market<\/a>:&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The point prevalence of Parkinson&#8217;s Disease-related Dementia is close to 30%, with an increased incidence rate of 4-6 times as compared to controls.<\/li>\n<li>It is found that Parkinson&#8217;s Disease-related Dementia is prevalent in at least 75% of Parkinson&rsquo;s Disease patients surviving for more than ten years.<\/li>\n<li>The mean period from the onset of Parkinson&rsquo;s Disease to dementia is around ten years, however, there are considerable variations with some patients developing dementia early in the disease course.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/parkinsons-disease-related-dementia-market?utm_source=Sheeran&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/parkinsons-disease-related-dementia-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Parkinson&#8217;s Disease Related Dementia Market Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Parkinson&#8217;s Disease Related Dementia , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Parkinson&#8217;s Disease Related Dementia epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Parkinson&#8217;s Disease Related Dementia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Parkinson&#8217;s Disease Related Dementia market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Parkinson&#8217;s Disease Related Dementia market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/parkinsons-disease-related-dementia-market?utm_source=Sheeran&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/parkinsons-disease-related-dementia-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Parkinson&#8217;s Disease Related Dementia Symptoms &amp; Causes:<\/strong><\/p>\n<p style=\"text-align: justify;\">Common symptoms of Parkinson&rsquo;s disease dementia include changes in energy levels, delusions, hallucinations, changes in appetite, paranoid ideas, depression, forgetfulness, increased anxiety, slurred speech, etc.<\/p>\n<p style=\"text-align: justify;\">Parkinson&rsquo;s disease disrupts the nerve cells that produce dopamine &#8211; a chemical messenger, without which the nerve cells can&rsquo;t relay instructions properly to the body. With further progression of the disease, it spreads in the brain, affecting the parts of the brain responsible for memory, mental functions, and judgment. Over time, the brain is unable to use these areas efficiently, thus causing the onset of Parkinson&rsquo;s disease dementia.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of Parkinson&#8217;s Disease Related Dementia Companies:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>ACADIA Pharmaceuticals<\/li>\n<li>Anavex Life Sciences<\/li>\n<li>Alkahest<\/li>\n<li>Enterin Inc.<\/li>\n<li>And many others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/parkinsons-disease-related-dementia-market?utm_source=Sheeran&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Parkinson&#8217;s Disease Related Dementia Therapies<\/a> Covered:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Nuplazid (pimavanserin)<\/li>\n<li>ANAVEX2-73<\/li>\n<li>GRF6021<\/li>\n<li>Active Investigational Treatment ENT-01<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: https:\/\/www.delveinsight.com\/sample-request\/parkinsons-disease-related-dementia-market<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Parkinson&#8217;s Disease Related Dementia<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Parkinson&#8217;s Disease Related Dementia<\/p>\n<p style=\"text-align: justify;\">4. Parkinson&#8217;s Disease Related Dementia : Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Parkinson&#8217;s Disease Related Dementia : Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Parkinson&#8217;s Disease Related Dementia Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Parkinson&#8217;s Disease Related Dementia Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">13. Parkinson&#8217;s Disease Related Dementia : Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Parkinson&#8217;s Disease Related Dementia<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\">23. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About Delveinsight:&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.<\/p>\n<p style=\"text-align: justify;\">Know more about our competitive intelligence services.<\/p>\n<p style=\"text-align: justify;\">Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=parkinsons-disease-related-dementia-market-disease-risk-burden-unmet-needs-and-other-insights-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/parkinsons-disease-related-dementia-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/parkinsons-disease-related-dementia-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/parkinsons-disease-related-dementia-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=parkinsons-disease-related-dementia-market-disease-risk-burden-unmet-needs-and-other-insights-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Parkinson&#8217;s Disease Related Dementia Market DelveInsight&#8217;s &#8220;Parkinson&#8217;s Disease Related Dementia Market Insights, Epidemiology, and Market Forecast-2030&#8243;&nbsp;report delivers an in-depth understanding of the Parkinson&#8217;s Disease Related Dementia , historical and forecasted epidemiology as well as the Parkinson&#8217;s Disease Related Dementia market &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/parkinsons-disease-related-dementia-market-disease-risk-burden-unmet-needs-and-other-insights-by-delveinsight_572855.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-572855","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/572855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=572855"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/572855\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=572855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=572855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=572855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}